BlackRock’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.91B Buy
8,947,735
+206,465
+2% +$158M 0.12% 134
2025
Q4
$6.75B Sell
8,741,270
-95,904
-1% -$65.1M 0.11% 134
2025
Q3
$4.97B Sell
8,837,174
-438,911
-5% -$248M 0.09% 191
2025
Q2
$4.87B Buy
9,276,085
+350,205
+4% +$195M 0.09% 180
2025
Q1
$5.66B Buy
8,925,880
+194,258
+2% +$134M 0.12% 145
2024
Q4
$6.22B Buy
8,731,622
+251,360
+3% +$211M 0.13% 132
2024
Q3
$8.91B Buy
8,480,262
+33,896
+0.4% +$37.7M 0.19% 90
2024
Q2
$8.88B Sell
8,446,366
-122,288
-1% -$119M 0.2% 84
2024
Q1
$8.25B Sell
8,568,654
-61,053
-0.7% -$58.1M 0.19% 92
2023
Q4
$7.58B Sell
8,629,707
-245,602
-3% -$202M 0.19% 91
2023
Q3
$7.3B Sell
8,875,309
-210,673
-2% -$166M 0.21% 80
2023
Q2
$6.53B Sell
9,085,982
-332,318
-4% -$256M 0.18% 98
2023
Q1
$7.74B Buy
9,418,300
+251,483
+3% +$190M 0.23% 75
2022
Q4
$6.61B Sell
9,166,817
-320,426
-3% -$236M 0.21% 88
2022
Q3
$6.54B Sell
9,487,243
-847
-0% -$533K 0.22% 79
2022
Q2
$5.61B Sell
9,488,090
-96,861
-1% -$63M 0.18% 94
2022
Q1
$6.69B Sell
9,584,951
-25,920
-0.3% -$16.4M 0.18% 94
2021
Q4
$6.07B Buy
9,610,871
+244,009
+3% +$150M 0.15% 107
2021
Q3
$5.67B Buy
9,366,862
+333,312
+4% +$207M 0.16% 107
2021
Q2
$5.05B Sell
9,033,550
-615,998
-6% -$312M 0.14% 122
2021
Q1
$4.57B Sell
9,649,548
-126,638
-1% -$61.7M 0.13% 129
2020
Q4
$4.72B Sell
9,776,186
-15,866
-0.2% -$8.56M 0.15% 116
2020
Q3
$5.48B Buy
9,792,052
+2,479
+0% +$1.5M 0.2% 86
2020
Q2
$6.11B Buy
9,789,573
+3,191,724
+48% +$1.81B 0.24% 74
2020
Q1
$3.22B Buy
6,597,849
+459,001
+7% +$189M 0.16% 121
2019
Q4
$2.31B Sell
6,138,848
-120,638
-2% -$40.6M 0.09% 212
2019
Q3
$1.74B Buy
6,259,486
+213,834
+4% +$63.3M 0.07% 260
2019
Q2
$1.89B Buy
6,045,652
+2,744
+0% +$914K 0.08% 239
2019
Q1
$2.48B Buy
6,042,908
+113,683
+2% +$46.8M 0.11% 179
2018
Q4
$2.21B Buy
5,929,225
+67,241
+1% +$24.6M 0.11% 175
2018
Q3
$2.37B Sell
5,861,984
-128,855
-2% -$49M 0.1% 189
2018
Q2
$2.07B Sell
5,990,839
-11,286
-0.2% -$3.53M 0.1% 205
2018
Q1
$2.07B Sell
6,002,125
-9,630
-0.2% -$3.35M 0.1% 202
2017
Q4
$2.26B Sell
6,011,755
-117,640
-2% -$47.6M 0.11% 186
2017
Q3
$2.74B Sell
6,129,395
-58,872
-1% -$28M 0.14% 143
2017
Q2
$3.04B Buy
6,188,267
+41,406
+0.7% +$18.1M 0.16% 121
2017
Q1
$2.38B Buy
6,146,861
+5,967,733
+3,332% +$2.21B 0.13% 155
2016
Q4
$65.8M Sell
179,128
-26,565
-13% -$10.1M 0.09% 250
2016
Q3
$82.7M Buy
205,693
+19,015
+10% +$7.63M 0.12% 191
2016
Q2
$65.2M Buy
186,678
+38,173
+26% +$14.7M 0.1% 227
2016
Q1
$53.5M Sell
148,505
-47,863
-24% -$19.7M 0.09% 264
2015
Q4
$107M Sell
196,368
-7,543
-4% -$4.09M 0.16% 149
2015
Q3
$94.8M Sell
203,911
-5,553
-3% -$2.98M 0.15% 165
2015
Q2
$107M Sell
209,464
-38,020
-15% -$18.6M 0.16% 145
2015
Q1
$112M Sell
247,484
-3,580
-1% -$1.52M 0.15% 151
2014
Q4
$103M Sell
251,064
-254
-0.1% -$99.9K 0.15% 154
2014
Q3
$90.6M Sell
251,318
-24,673
-9% -$8.27M 0.13% 169
2014
Q2
$78M Buy
275,991
+21,273
+8% +$6.3M 0.12% 197
2014
Q1
$76.5M Buy
254,718
+10,343
+4% +$3.19M 0.12% 187
2013
Q4
$67.3M Buy
244,375
+61,837
+34% +$17.8M 0.11% 209
2013
Q3
$57.1M Buy
182,538
+20,697
+13% +$5.44M 0.11% 208
2013
Q2
$36.4M Buy
+161,841
New +$37.7M 0.07% 280

Other funds holding REGN